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Abstract
Lipid-loaded macrophages were produced in vitro by incubation with acetylated or copper-oxidized LDL. In order to
establish whether cellular membrane traffic is generally perturbed by such loading, we assessed endocytosis of fluid; cell
surface binding, internalisation and degradation of a soluble ligand and of a particulate preparation; and exocytosis of
lysosmal enzymes. Fluid-phase pinocytosis of sucrose was unaffected by either form of loading. Binding, uptake and
 .  .degradation of soluble mannosylated-BSA and particulate zymosan ligands by these lipid-loaded and by non-loaded cells
were compared. Loading with oxidized LDL decreased the processing of both ligands, while loading with acetylated LDL
 .had little effect. Loading with oxidized LDL Ox-LDL also decreased zymosan binding at 48C; and the internalisation and
degradation of ligands in Ox-LDL loaded and non-loaded cells reflected the extent of surface binding. Changes in binding
and uptake of mannosylated-BSA and zymosan were not due to changes in viability or cell number. Zymosan stimulated
release of lysosomal b-N-acetyl-D-glucosaminidase from the cells. Loading with Ox- but not Ac-LDL decreased b-N-
acetyl-D-glucosaminidase secretion. After incubation with zymosan, intracellular levels of the enzyme were increased in the
Ox-LDL loaded cells. Zymosan uptake and b-N-acetyl-D-glucosaminidase secretion were correlated, but enzyme activity
per culture rose more in the absence than in the presence of zymosan. We conclude that membrane traffic is perturbed in
model foam cells, particularly those loaded with Ox-LDL.
Keywords: LDL; Foam cell; Macrophage; Endocytosis; Lysosomal enzyme; Atherosclerosis
Abbreviations: Ac-LDL, acetylated low-density lipoprotein;
BCA, bicinchoninic acid; BSA, bovine serum albumin; DMEM,
Dulbecco’s modification of Eagles medium; HDL, high-density
lipoprotein; HPLC, high performance liquid chromatography;
LDL, low-density lipoprotein; LPDS, lipoprotein deficient serum;
Ox-LDL, oxidized low-density lipoprotein; S.D., standard devia-
tion from the mean; S.E.M., standard error of the mean; PBS,
phosphate buffered saline; VLDL, very low-density lipoprotein
)  .Corresponding author. Fax: q61 2 9550 3302; E-mail:
r.dean@hri.edu.au
1. Introduction
Lipid-loaded macrophage foam cells are character-
istic of early atherosclerotic lesions. They are thought
to arise by uptake of modified forms of LDL such as
are recognised by scavenger receptors on the cell
surface. Uptake via this pathway is not regulated by
 w x.intracellular cholesterol loading reviewed 1 and so
can result in excess accumulation of lipid, visible as
cytoplasmic droplets. In vitro this can be achieved by
incubating macrophages with chemically or biologi-
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 .cally modified LDL e.g. acetylated or oxidized LDL .
LDL recovered from human atherosclerotic lesions
shows increased electrophoretic mobility and in-
creased fragmentation of apo-B suggesting that ox-
w xidative modification had occurred 2 . Therefore, LDL
may become oxidized in the vessel wall resulting in a
form of LDL which can load cells with lipid. How-
ever, the consequences of lipid loading for
macrophage function are at present poorly under-
stood.
One of the key functions of the macrophage is
uptake and degradation of a variety of foreign organ-
isms and endogenous proteins. Macrophages express
numerous cell surface receptors which are involved
 .in this process, including complement receptors CR ,
 .Fc receptors FcR and lectin receptors. Following
uptake, the majority of ligands are transported to the
lysosomes where they become degraded. There is
evidence to suggest that ligand uptake is dependent
on both membrane lipid composition, which affects
w xfluidity 3 , and on the size of the intracellular vesicu-
lar compartment. It appears that this compartment can
be expanded to a threshold level beyond which fur-
w xther ligand uptake is impaired 4 .
Certain particles such as zymosan, a component of
yeast cell walls, are inefficiently degraded within the
lysosomes and stimulate secretion of lysosomal en-
zymes and oxygen metabolites into the extracellular
environment. Oxidized LDL also appears to be poorly
catabolized by macrophages in vitro as evidenced by
w xlysosomal accumulation of the Apo B moiety 5,6 .
This is in contrast to acetylated LDL which is rapidly
catabolized, although both modified forms of LDL
w xcause some accumulation of intracellular lipid 7,8 .
Therefore, we hypothesized that intracellular accu-
mulation of lipids, by expanding the vesicular com-
partment and altering membrane lipid composition,
would cause impaired uptake and degradation of
ligands. We also hypothesised that an alteration in
cellular lipid composition and impaired ligand uptake
might inhibit lysosomal enzyme release. Such abnor-
malities in handling of exogenous materials by foam
cells might contribute to the pathogenesis of athero-
sclerosis.
We have indeed found that cells loaded with oxi-
dized LDL show impaired binding and uptake of
ligands. Furthermore, the addition of particulate ma-
terial such as zymosan to these cells caused less
b-N-acetyl-D-glucosaminidase secretion than from
non-lipid-loaded cells. Loading cells with acetylated
LDL did not cause an impairment in ligand uptake
although secretion of b-N-acetyl-D-glucosaminidase
was still slightly reduced when compared to non-
loaded cells.
2. Methods
2.1. Materials
Dulbecco’s modification of Eagles medium
 .  .DMEM was from Cytosystems Sydney, Australia .
Zymosan A from Saccharomyces cerevisiae was ob-
tained from Sigma. Mannosylated-BSA was from
E-Y Laboratories, USA.
2.2. LDL preparation
 .Human LDL density 1.019–1.050 was isolated
from fresh plasma of fasted normolipidaemic volun-
 . teers collected into EDTA 3 mM , aprotinin 90
.kallikrein inhibitory unitsrml and soybean trypsin
 .inhibitor 20 mgrml . LDL was isolated by a single
ultracentrifugation step in a vertical rotor Beckman
.VTi50 using a discontinuous KBr gradient for 2.5 h
w xat 242 000=g 9 . The LDL was washed to remove
contaminating albumin by a second overnight cen-
trifugation at a density of 1.063 in an angle rotor
 .Beckman Ti70 and then dialysed for 24 h against
several changes of 50–100 volumes of PBS contain-
ing 1.0 mgrml EDTA and 0.1 mgrml chloramphe-
nicol. All dialysis solutions were deoxygenated by
bubbling with nitrogen and all dialyses were per-
formed under near-anoxic conditions at 48C in filled,
stoppered bottles to minimise LDL oxidation during
these preparative steps.
2.3. LDL modifications
Copper-mediated oxidation was achieved by incu-
 .bating LDL 400 mg proteinrml , which had been
dialysed for 24 h against several changes of PBSq
 .Chelex BioRad to remove EDTA, in PBS with a
 .sterile solution of CuCl final concentration 10 mM2
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at 378C for 24 h. The relative electrophoretic mobility
as determined by agarose gel electrophoresis was
 .4.4"0.1 ns3 in comparison to unmodified LDL.
w xLDL was acetylated as described previously 10 ,
using 6 ml acetic anhydridermg LDL protein. Excess
acetic anhydride was removed by dialysis with sev-
eral changes of PBSqChelex. The relative elec-
trophoretic mobility as determined by agarose gel
 .electrophoresis was 3.6"0.2 ns3 , in comparison
to unmodified LDL.
( )2.4. Lipoprotein deficient serum LPDS preparation
Lipoprotein depleted plasma was prepared by re-
moval of all lipoproteins from plasma obtained from
fasted normolipidaemic volunteers. Briefly, VLDL
and LDL were removed by ultracentrifugation in a
w xvertical rotor using a discontinuous KBr gradient 9 .
 .The highest density fraction d)1.085 , was recov-
ered and density adjusted to 1.24 with solid KBr.
Following 22 h centrifugation at 242 000=g, the
supernatant HDL was discarded and the dense,
lipoprotein-deficient plasma fraction was recovered
and dialysed against 5 l 0.15 M NaCl. 55 U throm-
 .binr100 ml LPDS and 10 mM final concentration
CaCl were added to the lipoprotein deficient plasma2
and coagulation allowed to occur for 1 h at room
temperature. The clot was removed and the resulting
 .lipoprotein deficient serum LPDS filter sterilised
 .  .0.2 mm . LPDS was used at 10% vrv in culture
media where indicated equivalent to 1.5 mg pro-
.teinrml final concentration in cultures .
2.5. Cell culture
Resident peritoneal macrophages were harvested
w xfrom QS mice as previously described 5 . Cells were
plated in 22 mm wells at 2=106rwell and non-ad-
herent cells removed after 2 h incubation at 378C by
washing three times with 1 ml PBS at room tempera-
 .ture. Copper-oxidized LDL Ox-LDL or acetylated
 .LDL Ac-LDL was added at 25 mg proteinrml in
DMEM containing 10% LPDS and incubated for 24
h at 378C. Control, non-loaded cells were prepared
under the same conditions without the addition of
LDL. Cells were then washed three times with PBS
as above to remove exogenous LDL prior to use.
2.6. HPLC analysis
Cholesterol, cholesterol esters and their oxidation
products were extracted from individual cell cultures
w xas described previously 11 . Briefly, cells were lysed
with 0.6 ml 0.2 M NaOH on ice, then 0.4 ml lysate
mixed with 0.6 ml PBS, then 2.5 ml ice-cold methanol
followed by 10 ml hexane. Samples were vortexed
vigorously after each extraction, then centrifuged at
1700 rpm at 48C for 4 min. Samples were stored at
y808C. 8 ml of the hexane layer was removed,
evaporated under vacuum, and then re-dissolved in
250 ml of HPLC eluant. Of this, 75 ml was injected
onto a reverse-phase C-18 column. Analysis of
cholesterol and cholesterol esters was performed by
detecting 210 nm absorbance after elution with aceto-
 .nitrilerisopropanol 30r70, vrv and oxidized
derivatives of cholesterol and cholesterol esters in-
.cluding 7-ketocholesterol were detected by their ab-
sorbance at 234 nm after elution with aceto-
 .nitrilerisopropanolrwater 44r54r2, vrvrv .
2.7. Preparation of ligands
Mannosylated-BSA was iodinated using the solid-
phase oxidant iodogen to a specific activity of ap-
prox. 170 cpmrng. 100 ml mannosylated-BSA 1
. mgrml and 100 ml sodium borate buffer 100 mM,
.pH 8.5 were added to the iodination vial followed by
125  .10 ml Na I 1 mCi . The vial was left for 15 min at
room temperature then the solution removed and
dialysed for 24 h against several changes of PBS.
 .Following filter sterilisation 0.2 mm the protein
concentration was determined by BCA assay Sigma
.kit .
Zymosan was also iodinated using iodogen to a
specific activity of approx. 25 cpmrng. 100 ml of 40
mgrml zymosan and 100 ml sodium borate buffer
 .100 mM pH 8.5 were added to the iodination vial
125  .followed by 10 ml Na I 1 mCi . The vial was left
for 15 min at room temperature and then 1 ml PBS
added to terminate the reaction. The vial was cen-
trifuged for 1 min to precipitate the zymosan. The
precipitate was resuspended in PBS, boiled for 2 min
in a microwave oven, then removed to a clean tube
and washed a further three times with PBS. The
iodinated zymosan was stored at 48C for up to 2
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weeks and centrifuged immediately before each use
to remove free iodide.
2.8. Measurement of fluid-phase pinocytosis
Cell cultures were incubated with radiolabelled
3 . tracer: 10 ml H sucrose 10 mCi; Amersham, 12
.Cirmmol sucrose was added to each culture, which
contained 1 ml DMEM supplemented with 10%
LPDS. Cultures were harvested after 0 and 24 h at
378C by washing 5 times with cold PBS, then lysed
 .by addition of 1 ml NaOH 0.1 M . 0.5 ml cell lysate
was added to 5 ml Ultima Gold Scintillation Cocktail
 .Canberra Packard and counted for 10 min in a LKB
1214 Rackbeta liquid scintillation counter. Quench
was corrected automatically based on external stan-
dards. We had previously found pinocytosis in this
system to be linear from 1–24 h. The volumes of
fluid pinocytosed were calculated and expressed as
mlrmg cell proteinrh. Cell free samples were incu-
bated in parallel and gave a background of -10% of
counts taken up by non-loaded cells.
2.9. Measurement of endocytosis
Cell cultures were washed three times with PBS to
remove lipoprotein containing medium. Radiolabelled
ligands were then diluted to the required concentra-
tion in DMEM supplemented with 10% LPDS. Man-
nosylated-BSA was added to cells at 10 mgrml,
while zymosan was added at 50 mgrml in a total
volume of 1 ml. Cultures were incubated for 0, 2, 6
or 24 h at 378C. 0.5 ml supernatant was then removed
 .and 50 ml BSA 30 mgrml added, followed by 1 ml
 .ice-cold TCA 10% and incubated at 48C for 30 min.
250 ml of 0.7 M AgNO was then added to precipi-3
.tate free iodide , mixed and the samples centrifuged
at 1500=g and 48C for 10 min. 0.5 ml of the
resulting supernatant iodide-free, TCA-soluble
.degradation products was removed and counted. The
remaining medium was removed from cultures by
aspiration, and the cells washed three times with
ice-cold PBS. The cells were then lysed by addition
 .of 1 ml NaOH 0.1 M and total cell-associated
activity measured. Total endocytosis was defined as
cell associated plus degradation products. Binding
was measured by incubation for 2 h at 48C in sealed
plates. Cells were washed three times with ice-cold
 .PBS and lysed by addition of 1 ml NaOH 0.1 M
and cell-associated activity measured. Cell free sam-
ples were included at all time points and the counts
associated with them have been subtracted from the
data presented. Levels of radioactivity remaining on
 .the cell free tissue culture plates NaOH fraction
were very low, and always represented less than 25%
of the lowest levels detected in the presence of cells.
2.10. Measurement of lysosomal enzyme release
Lysosomal enzyme release was stimulated by the
addition of 50 mgrml unopsonized zymosan for
various times in a final volume of 1 mlrwell DMEM
containing 10% LPDS, while control unstimulated
cells were incubated under the same conditions in the
absence of zymosan. Enzyme activity was measured
in both supernatants and cell lysates prepared by
 .addition of Triton X-100 0.1% . b-N-acetyl-D-gluco-
 .saminidase EC 3.2.1.30 was chosen as the marker
enzyme as its release does not require protein synthe-
w xsis 12 . The assay was conducted under conditions
which gave linear release of product in relation to the
amount of sample used and the time of incubation.
b-N-acetyl-D-glucosaminidase activity was deter-
mined by release of p-nitrophenol from p-
 .nitrophenyl-N-acetyl glucosaminide pNP-NAG . The
reaction mixture contained 120 ml culture super-
natant or cell lysate and 600 ml of 0.66 mgrml
 .pNP-NAG in citric acidrphosphate buffer pH 4.5 .
The mixture was incubated at 378C for 1.5 h then the
reaction stopped by addition of 600 ml 0.2 M glycine
and the absorbance read at 405 nm. The absorbance
values were converted into nmoles of product p-
.nitrophenol by use of a standard curve prepared with
p-nitrophenol. The results were calculated initially as
nmol substrate convertedrh and shown as nmol sub-
straterh per mg cell protein, or as percentage of total
intracellular enzyme released.
( )2.11. Measurement of lactate dehydrogenase LDH
release
Release of lactate dehydrogenase a cytoplasmic
.enzyme was used as an index of cell lysis. LDH
activity was measured by conversion of pyruvic acid
to lactic acid in the presence of NADH. 100 ml of
 .culture supernatant or cell lysate in Triton X-100
 .was added to 200 ml pyruvic acid 550 mM contain-
ing 1 mgrml NADH. After incubation for 1 h at
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378C, 200 ml colour reagent Sigma; 2,4- dinitro-
.phenylhydrazine was added to detect the presence of
remaining pyruvic acid and followed by a further
 .incubation for 30 min at 508C. 2 ml NaOH 0.4 M
was added and absorbance determined at 450 nm.
The absorbance values were converted to moles of
pyruvic acid by means of a standard curve and results
then expressed as either enzyme units or percentage
of intracellular enzyme released. LDH enzyme units
are defined as mmol substrate convertedrmin at
378C.
2.12. Protein assay
Cells were lysed by addition of either 1 ml NaOH
 .0.1 M or 1 ml 0.1% Triton X-100rwell as speci-
fied. Protein concentration was determined by BCA
 .assay Sigma kit using BSA standards in either
NaOH or Triton where samples were also to be used
for enzyme assays.
2.13. Trypan blue staining
Cell viability was assessed by trypan blue exclu-
sion. Cells were loaded with Ox-LDL or Ac-LDL as
described above for 24 h. After washing three times
 .with PBS at room temperature 0.5 ml 20% vrv
trypan blue was added and incubated at room temper-
ature for 5 min. The trypan blue was removed by
aspiration and uptake determined microscopically.
Cells taking up trypan blue were assumed to be
non-viable.
2.14. Data presentation
Unless otherwise stated, data reported are means
 ."S.D. from individual experiments ns3 which
were representative of several. Statistical analysis
was performed using Student’s t-tests.
3. Results
3.1. Characterisation of lipid-loaded cells
Lipid-loaded cells were produced in vitro by incu-
bation of murine peritoneal macrophages with oxi-
dized or acetylated LDL as described above. Lipid
accumulation was assessed by Oil Red O staining and
HPLC analysis of intracellular oxidized and unoxi-
w xdized cholesterol derivatives 11 . Loading with both
oxidized and acetylated LDL resulted in accumula-
tion of Oil Red O positive droplets in the cytoplasm
w x7 . Loading with 25 mgrml oxidized LDL for 24 h
caused a net accumulation of 101"16 nmol choles-
terol and cholesterol estersrmg cell protein and 27"
4 nmol 7-ketocholesterolrmg cell protein, while
loading with 25 mgrml acetylated LDL caused the
accumulation of 165"27 nmol cholesterol and
cholesterol estersrmg cell protein and no 7-keto-
cholesterol was detected in these cells. It is now well
established that oxidation of LDL involves consump-
tion of cholesterol esters, and thus that oxLDL-loaded
cells have smaller amounts of these esters than their
 w x.Ac-LDL loaded counterparts for example 7,8,11 .
The present ranges of cholesterol and cholesterol
ester accumulation following Ac-LDL loading are
w xsimilar to those reported by others 13 . In contrast to
these loaded cells, our non-loaded cells contained
approx. 47"6 nmol cholesterolrmg cell protein and
no detectable cholesterol esters or 7-ketocholesterol.
Cell viability was assessed by trypan blue staining
 .and release of lactate dehydrogenase LDH , a cyto-
plasmic enzyme, into the culture supernatant. Follow-
ing incubation with LDL all cultures were )90%
viable. In some experiments there was a slight drop
in viability during the course of subsequent incuba-
tions, to approx. 70%. There was however no signifi-
cant difference in cell viability or protein concentra-
tion following loading with either Ox-LDL or Ac-
LDL in comparison to the non-loaded cells.
3.2. Fluid-phase pinocytosis is not affected by lipid
loading
Prior to measuring endocytosis of soluble and
particulate ligands by lipid-loaded cells we wished to
establish if fluid-phase pinocytosis was altered fol-
w3 xlowing lipid accumulation using H sucrose as a
measure of fluid-phase pinocytosis. This was impor-
tant as we had hypothesized that lipid loading, by
expanding the vesicular compartment might inhibit
further vesicle formationrinternalisation of extracel-
lular components. This might therefore apply to both
basal membrane internalisation during fluid-phase
pinocytosis as well as uptake of macromolecules
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which bind to surface receptors. Cells loaded with
Ox-LDL took up 0.25"0.03 mlrmg cell proteinrh
while Ac-LDL loaded cells took up 0.34"0.07
mlrmg cell proteinrh compared to 0.26"0.07
mlrmg cell proteinrh taken up by non-loaded cells
results from one experiment which was representa-
.tive of two others . This level of fluid-phase uptake is
w xsimilar to that reported by others 14,15 . These data
indicate that fluid-phase pinocytosis was not signifi-
cantly altered as a result of lipid loading; and confirm
the general functionality of the cells.
3.3. Uptake of mannosylated-BSA is reduced by Ox-
LDL loading but not with Ac-LDL loading
Endocytosis of soluble ligands by lipid-loaded cells
was determined by measurement of mannosylated-
BSA uptake and degradation. Total endocytosis cell
.associated plus degraded ligand of mannosylated-
BSA was reduced by approximately 50% following
Ox-LDL loading, while uptake following Ac-LDL
loading was not significantly different from that of
 .non-loaded cells Fig. 1 . Changes in the rate of
ligand degradation following Ox-LDL or Ac-LDL
Fig. 1. Mannosylated-BSA binding and endocytosis by lipid-
loaded macrophages. Surface binding of mannosylated-BSA was
determined after 2 h at 48C while endocytosis cell associatedq
.degraded was measured after incubation for 6 h at 378C. Results
are expressed as ng BSA per mg cell protein and represent the
 . mean"SEM ns3 from three independent experiments each
.performed in triplicate . Non-L represents non-loaded cells, Ox-
LDL represents oxidized LDL loaded cells, Ac-LDL represents
acetylated LDL loaded cells. ) Binding to Ox-LDL and Ac-LDL
loaded cells was slighter than to Non-Loaded P -0.01 and
.-0.05 respectively , while differences in endocytosis between
the Ox-LDL loaded and the other two cell types were significant
at P -0.01.
Fig. 2. Zymosan binding and endocytosis by lipid-loaded
macrophages. Surface binding of zymosan was determined after 2
h at 48C while cell associatedqdegraded material was measured
after incubation for 6 h at 378C. Results are expressed as mg
 .zymosanrmg cell protein and represent the mean"S.D. ns3
from one experiment that was representative of three others.
Non-L represents non-loaded cells, Ox-LDL represents oxidized
LDL loaded cells, Ac-LDL represents acetylated LDL loaded
cells. ) Ox-LDL cell zymosan binding and endocytosis signifi-
cantly different from corresponding non-L or Ac-LDL values;
Ac-LDL binding values significantly greater than those for Non-L
 .or Ox-LDL P -0.05 in each case .
loading closely correlated with the changes in uptake,
with 90–99% of internalised ligand appearing as low
molecular weight degradation products in the cell
supernatant in all cultures after 6 h. When cells were
loaded with Ox-LDL, the decrease in uptake of man-
nosylated-BSA was found to correlate quite well with
a decrease in cell surface binding at 48C. Both bind-
ing and endocytosis were significantly different from
 .those of non-loaded cells P-0.01 . A modest re-
duction in binding was seen when cells were loaded
 .with Ac-LDL P-0.05 vs. non-loaded cells , al-
though the extent of mannosylated-BSA internalisa-
tion by these cells was not significantly different
from that of non-loaded cells.
3.4. Handling of zymosan is also reduced in Ox-LDL
loaded cells
The uptake of particulate ligands may involve
processes distinct from those employed during recep-
tor-mediated uptake of soluble ligands. We therefore
studied binding and degradation of zymosan, a yeast
cell wall component, by lipid-loaded cells. Like man-
nosylated-BSA, zymosan is also recognised by the
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Table 1
Zymosan uptake by lipid loaded cells and its effect on lysosomal enzyme secretion and cell viability
Cell type Zymosan b-N-acetyl-D-glucosaminidase Lactate dehydrogenase
Internalised Degraded Secreted Total % Secreted Released Total % Released
 .  .  .  .  .  .mgrmg mgrmg nmolrhrmg nmolrh per mg mUrmg mUrmg
Non-L 26"7 420"28 6"2 1.5"0.4 14.8"2.3 10"2
Non-L 805"97 45"9 176"10 339"9 52"2 3.5"1.0 15.8"1.7 22"5
q Zymosan
Ox-LDL 30"3 516"28 6"1 2.1"1.1 21.9"3.0 10"5
a bOx-LDL 530"192 13"4 83"12 435"14 19"2 2.0"0.4 14.5"0.6 14"2
q Zymosan
Ac-LDL 27"1 470"38 6"0 1.2"0.4 18.3"1.1 6"2
c dAc-LDL 910"90 71"18 156"13 373"15 42"3 2.6"0.6 16.4"3.2 16"1
q Zymosan
 .  .  .Cells loaded with oxidized LDL Ox-LDL or acetylated LDL Ac-LDL were compared with non-loaded non-L cells. Cultures were
 . 125incubated with qzymosan rwithout 50 mgrml I-zymosan for 6 h. Total enzyme activity represents the sum of secretedq intra-
cellular activity. Lysosomal enzyme secretion can be gauged by b-N-acetyl-D-glucosaminidase release. LDH release induced by zymosan
 .is significantly enhanced in the non-loaded and Ac-LDL conditions P-0.01 , but the enhancement is much smaller than that of
lysosomal enzyme release, indicating that the latter is genuine secretion. Results shown are the mean"S.D. of triplicate cultures from
one experiment which was representative of two others. All activity data are expressed per mg cell protein.
a  .  . b  . Ps0.001 vs. non-Lqzymosan and 0.002 vs. Ac-LDLqzymosan , Ps0.001 vs. non-Lqzymosan and 0.007 vs. Ac-LDLq
. c  . d  .zymosan , Ps)0.1 vs. non-Lqzymosan , Ps0.030 vs. non-Lqzymosan .
mannose receptor on macrophages, although other
receptors may also be involved, particularly in the
presence of serum, which causes opsonisation of the
zymosan particles.
Binding of zymosan was found to be reduced by
approx. 60% following Ox-LDL loading in compari-
 .son to non-loaded cells Fig. 2 . This was paralleled
by a decrease in zymosan degradation when com-
 .pared to non-loaded cells Table 1 , and also in
 .overall endocytosis Fig. 2 . Endocytosis was mea-
 .sured at 6 h Fig. 2 , at which time the intracellular
pool has reached a maximum, which is maintained
 .until at least 24 h data not shown . Unlike mannosy-
lated-BSA, the majority of internalised zymosan does
not become rapidly degraded but is stored within the
cell. Ac-LDL loaded cells bound somewhat more
 .zymosan than non-loaded cells Fig. 2 , though the
overall endocytosis and catabolism of the zymosan
was not changed.
It appears that phagocytosis, as well as receptor-
mediated endocytosis of soluble ligands, is altered
following lipid loading and that the type of lipid used
for loading influenced the response. Ox-LDL loading
caused significant interference with the handling of
both mannosylated-BSA and zymosan and in both
cases this was associated with a decrease in ligand
binding. Ac-LDL loading did not significantly alter
uptake of mannosylated-BSA or zymosan despite
some differences in cell surface binding of these
ligands.
3.5. Secretion of lysosomal enzymes is reduced after
Ox-LDL loading
Zymosan phagocytosis is often used experimen-
tally to induce macrophage lysosomal enzyme secre-
tion. We hypothesised that as Ox-LDL loaded cells
bind and degrade less zymosan than non-loaded cells,
Fig. 3. b-N-acetyl-D-glucosaminidase levels in cultures of LDL-pre-loaded macrophages over 24 h with or without zymosan stimulation.
 .  .b-N-acetyl-D-glucosaminidase was measured in culture supernatants secreted and cell lysates intracellular at each time. Total
represents the sum of intracellular and secreted enzyme. Where indicated zymosan was included in the incubation medium for the
duration of the experiment. Neither Ac- nor Ox-LDL were present during the 24 h post-loading period shown. Results are the
 . )mean"S.D. ns3 of triplicate cultures from one experiment which was representative of two others. represents P value of -0.05
vs. Non-L.
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enzyme secretion in response to zymosan stimulation
would be reduced. If macrophages are cultured in the
presence of zymosan for more than 24 h, increased
w xlysosomal enzyme accumulation occurs 16 . There-
fore, it was possible that Ox-LDL loading which
results in lysosomal accumulation of Apo B might
similarly stimulate lysosomal enzyme secretion in the
absence of zymosan.
b-N-acetyl-D-glucosaminidase was used as a
marker of lysosomal enzyme activity with measure-
ment of LDH, a cytoplasmic enzyme to control for
enzyme loss from cell death. At 6 h post addition of
zymosan b-N-acetyl-D-glucosaminidase secretion by
Ox-LDL loaded cells was less than 50% of that
 .secreted by non-loaded cells Table 1 . This was not
explicable by the slight changes in viability as judged
by trypan blue exclusion and LDH release from the
cells. Loading with Ac-LDL had only a slight and
delayed effect on enzyme secretion in comparison to
 .non-loaded cells Fig. 3 . The levels of enzyme secre-
tion correlated with relative amounts of zymosan
 .internalised by each cell type Table 1 . After zy-
mosan stimulation, total levels of b-N-acetyl-D-glu-
 .cosaminidase intracellularqsecreted were higher in
cells loaded with either Ox-LDL or Ac-LDL than
non-loaded cells and this was selective for the lysoso-
mal system, since LDH total levels were hardly
 .affected Table 1 .
3.6. Ox-LDL loading enhances b-N-acetyl-D-gluco-
saminidase le˝els
To further investigate the effects of both lipid and
zymosan storage on the kinetics of lysosomal enzyme
levels and secretion we followed intracellular b-N-
acetyl-D-glucosaminidase levels and secretion over a
subsequent 24 h in the absence of further Ac- or
 .Ox-LDL Fig. 3 . Immediately following lipid load-
ing there were no significant differences between the
intracellular levels of b-N-acetyl-D-glucosaminidase
between Ox-LDL loaded, Ac-LDL loaded or non-
loaded cells. Zymosan stimulation resulted in in-
creased b-N-acetyl-D-glucosaminidase secretion from
all cells as shown above, the majority of secretion
 .occurring in the first 6 h Fig. 3A . Levels of enzyme
secreted from Ox-LDL loaded cells were approxi-
mately 50% lower than those secreted by non-loaded
cells at all time points. Interestingly, after 24 h
Ac-LDL loaded cells also secreted less b-N-acetyl-
D-glucosaminidase than non-loaded cells despite their
relatively greater degradation of zymosan. An initial
 .drop in intracellular levels Fig. 3B could be ac-
counted for by enzyme release exceeding enzyme
synthesis, provided that degradation was unchanged.
Between 6 and 24 h there appeared to be a slight
increase in total levels in non-loaded and Ac-LDL
 .loaded cells Fig. 3C . This increase was more pro-
nounced in Ox-LDL loaded cells and was presumably
due to de novo synthesis. If cells were incubated in
the absence of zymosan, there was very little b-N-
 .acetyl-D-glucosaminidase secretion Fig. 3D and in-
tracellular levels remained relatively constant for the
first 6 h, after which there were again increased total
 .levels of b-N-acetyl-D-glucosaminidase Fig. 3E ; in-
deed the increase in total enzyme activity was greater
in the absence than in the presence of zymosan. This
increase between 6 and 24 h was thus observed in all
cell types although the increase seen following Ox-
LDL loading was in each case slightly greater than
 .that seen in non-loaded cells P-0.05; Fig. 3F .
4. Discussion
Following loading with oxidized LDL we were
able to measure increased levels of the oxidized
sterol 7-ketocholesterol, in addition to increased lev-
els of free cholesterol in macrophages. The majority
of these LDL derived lipids are generally extra-lyso-
somal with free sterols distributed among membrane
fractions plasma membrane, endosomal and lysoso-
. w xmal 7 . The small amount of cholesterol esters
present exist as free cytoplasmic droplets. Some of
the oxidized Apo B however, is retained in the
w xlysosomes of these Ox-LDL loaded cells 5,6 . Load-
ing with acetylated LDL resulted in cells containing
much larger amounts of cholesteryl esters in addition
to increased free cholesterol but no 7-ketocholesterol.
Apo B of acetylated LDL appears to be quite effi-
ciently hydrolysed in the lysosomes and therefore
does not accumulate in these cells.
We have shown that storage of intracellular lipid
derived from either Ox-LDL or Ac-LDL did not alter
fluid-phase pinocytosis, indicating that the overall
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basal rate of membrane internalisation remained un-
changed. This is consistent with the finding that
zymosan phagocytosis by non-loaded cells does not
w xalter fluid-phase pinocytosis 17 , although extensi˝e
vacuolation of the endocytic compartment with su-
w xcrose does lower macrophage phagocytic capacity 4 .
Therefore there may be a limited capacity of cells to
internalise membrane components once the endo-
cyticrlysosomal compartment is expanded to a
threshold but lysosomal storage of much larger quan-
tities of material than achieved with the present Ox-
LDL loading is probably needed to impair sucrose
pinocytosis. Others have claimed that pinocytosis can
be inhibited independent of cell death by incubating
cells with oxidized LDL, although much higher con-
w xcentrations of oxidized LDL were used 14 . It has
been shown however, that oxidized LDL is toxic to
macrophages at high concentrations as measured by
tritiated adenine release, a sensitive indicator of cell
w xdamage 18 . The concentrations of oxidized LDL
which were shown to be toxic were much higher than
those used in the present study. Data on rabbit en-
dothelial and smooth muscle cells are consistent with
our conclusion that fluid phase pinocytosis is not
altered by the novel oxysterol components of Ox-
w xLDL, nor by cholesterol 19 . Thus while certain
oxysterols were inhibitory, these were not those pre-
sent in Ox-LDL in significant amounts; conversely,
neither cholesterol nor 7-ketocholesterol, the major
oxysterol in Ox-LDL, were inhibitory in relevant
concentration ranges.
When cells were loaded with Ox-LDL they re-
vealed reduced uptake andror degradation of both a
 .soluble ligand mannosylated-BSA and a particulate
 .ligand zymosan . This did not however appear to be
solely the result of the lysosomal alterations caused
by loading with lipid as these cells also showed
reduced surface binding of the ligands. Interestingly,
degradation of zymosan was impaired to a greater
extent than was cell surface binding or uptake of
zymosan which might suggest that not all zymosan is
reaching the lysosomes. Previous studies had not
revealed a decrease in uptake or degradation of man-
w xnosylated-BSA following Ox-LDL loading 5 . How-
 .ever, lower concentrations of Ox-LDL 10 mgrml
were used to load cells in these earlier experiments.
An impairment of phagocytosis has been shown to
occur in type IIa and type IIb hyperlipoproteinaemia
w x20 and phagocytosis of aggregated LDL is slightly
w xreduced when mice are fed a high fat diet 21 .
Therefore, an impairment in ligand uptake may occur
in vivo under conditions of increased LDL concentra-
tion, which might be correlated with increased cellu-
lar exposure to Ox-LDL.
Like Ox-LDL, Ac-LDL loading resulted in slightly
decreased surface binding of mannosylated-BSA, al-
though, in contrast, increased binding of zymosan
was detected. However, uptake of these ligands was
not significantly different from uptake by non-loaded
cells. Others have also shown that loading with Ac-
LDL fails to alter the FcR-mediated uptake of sheep
w xerythrocytes 22 . Therefore, lipid loading per se does
not inhibit uptake of the two ligands studied here,
although it does appear to alter the surface recogni-
tion of ligands. The special effects of oxidised lipid
loading thus seem to be concentrated upon the intra-
cellular handling of the ligands.
In agreement with this, oxidized LDL was found
to affect another intracellular membrane activity, the
secretion of b-N-acetyl-D-glucosaminidase. Secretion
of other lysosomal enzymes generally occurs in paral-
lel to b-N-acetyl-D-glucosaminidase secretion; there-
fore b-N-acetyl-D-glucosaminidase was used as a
marker of lysosomal enzyme activity. Loading with
Ox-LDL resulted in significantly less b-N-acetyl-D-
glucosaminidase being secreted from the cells in
response to a standard trigger, zymosan. This corre-
lated with decreased handling of zymosan by these
cells. Little difference in b-N-acetyl-D-glucosamini-
dase secretion or zymosan uptake between Ac-LDL
loaded and non-loaded cells was found. Therefore,
the decrease in enzyme secretion from Ox-LDL
loaded cells appeared to be related to their decreased
zymosan processing, suggestive of a direct onflow of
information within the intracellular vacuolar mem-
brane system. In agreement with this, Ox-LDL load-
ing substantially increased intracellular levels of b-
N-acetyl-D-glucosaminidase in the presence of zy-
mosan. There was no increase in cytoplasmic LDH
levels in any of the cells. This effect on intracellular
levels of a lysosomal enzyme may be similar to that
observed with other stored particles, particularly those
w xwhich are poorly degraded 16 .
We have shown that certain model foam cells,
those loaded with Ox-LDL but not Ac-LDL, show
impaired endocytosis of a soluble and a particulate
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ligand. The mechanism responsible for this effect is
unknown but probably represents an effect of certain
lipids derived from the LDL on ligand recognition
andror intracellular transport. Poor clearance of
damaged lipoproteins by intimal macrophages within
the early atherosclerotic lesion might contribute to
lesion progression by eliciting an immune response,
or stimulating cell-derived mediator release. De-
creased uptake of zymosan by Ox-LDL loaded cells
in comparison to non-loaded cells leads to decreased
release of the lysosomal enzyme b-N-acetyl-D-gluco-
saminidase and the intracellular levels this enzyme
are increased in these cells. If lipid loaded cells
within the atherosclerotic lesion eventually lyse the
levels of hydrolytic enzymes released into the sur-
rounding tissue would therefore be greater. Further
studies will be required to determine the components
of oxidized LDL responsible for these impairments.
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